- $263.91m
- $175.90m
- $145.38m
- 76
- 44
- 76
- 72
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 159 | 180 | 242 | 217 | 145 |
Cost of Revenue | |||||
Gross Profit | 52.3 | 62.4 | 86 | 79 | 52.9 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 154 | 166 | 284 | 271 | 187 |
Operating Profit | 5.03 | 14.3 | -41.5 | -53.9 | -41.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2.24 | 6.79 | -43.2 | -53.4 | -34.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.14 | 6.84 | -43.1 | -53.4 | -34.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -6.4 | 1.69 | -43.1 | -53.4 | -34.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -6.4 | 1.69 | -43.1 | -53.4 | -34.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.142 | -0.173 | -0.65 | -0.764 | -0.469 |